Cargando…
Risk of Metformin in Patients With Type 2 Diabetes With COVID‐19: A Preliminary Retrospective Report
The current outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection has spread across the world. No specific antiviral agents have been adequately evidenced for the treatment of coronavirus disease 2019 (COVID‐19). Although metformin has been recommended as a host‐dire...
Autores principales: | Gao, Yongchao, Liu, Tao, Zhong, Weijun, Liu, Rong, Zhou, Honghao, Huang, Weihua, Zhang, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537216/ https://www.ncbi.nlm.nih.gov/pubmed/32955785 http://dx.doi.org/10.1111/cts.12897 |
Ejemplares similares
-
Bacteroides ovatus accelerates metformin-induced vitamin B12 deficiency in type 2 diabetes patients by accumulating cobalamin
por: Chen, Manyun, et al.
Publicado: (2023) -
Development and Validation of a Predictive Nomogram with Age and Laboratory Findings for Severe COVID-19 in Hunan Province, China
por: Jiang, Junyi, et al.
Publicado: (2022) -
Chrysophanol Relieves Cisplatin-Induced Nephrotoxicity via Concomitant Inhibition of Oxidative Stress, Apoptosis, and Inflammation
por: Ma, Siqing, et al.
Publicado: (2021) -
Corrigendum: Chrysophanol Relieves Cisplatin-Induced Nephrotoxicity via Concomitant Inhibition of Oxidative Stress, Apoptosis, and Inflammation
por: Ma, Siqing, et al.
Publicado: (2021) -
Metformin and the Risk of Dementia in Type 2 Diabetes Patients
por: Chin-Hsiao, Tseng
Publicado: (2019)